| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 6, 2024 | CNS Pharmaceuticals, Inc. | Director | Buy | 90.0 | +33,333 | 344.60% | ✗ | $10K |
| Apr 19, 2023 | Apr 21, 2023 | CNS Pharmaceuticals, Inc. | Director | Buy | 90.0 | +2,500 | 34.85% | ✗ | $4.3K |
| Apr 10, 2023 | Apr 17, 2023 | CNS Pharmaceuticals, Inc. | Director | Buy | 90.0 | +7,173 | 100.00% | ✗ | $5.3K |